AI enhances mammography by reducing radiologists' workload by 40% while maintaining accuracy in breast cancer detection, ...

Explore how payers and providers collaborate to enhance value-based care, tackle rising costs, and improve patient outcomes ...

Climate-related disasters threaten US drug production, highlighting vulnerabilities in the pharmaceutical supply chain and the urgent need for strategic planning.

Jonathan Thompson, MD, MS, highlighted that reducing delays in molecular testing and treatment initiation is critical for improving lung cancer outcomes, and that clinical trial data suggest ...

A novel image-based deep learning approach achieves high accuracy and interpretability, offering potential for clinical ...

National Psoriasis Awareness Month offers an opportunity to examine how advances in systemic therapy, combined with ...

Jenny Craven, PharmD, BCPS, outlines the strategies UC Davis Health has used to successfully navigate the complex challenges of implementing cell and gene therapies.

A UK cohort study finds socioeconomic deprivation in early life is tied to greater eating disorder symptoms in adolescence, with barriers to care.

Lauren Wisk, PhD, discusses the implications of an all-inclusive long COVID definition and its application in clinical practices.

Today, the FDA issued a complete response letter (CRL) for vatiquinone (PTC Therapeutics), delaying its potential approval as a treatment for Friedreich ataxia amid efficacy concerns.

Definitive conclusions regarding the association between semaglutide and nonarteritic anterior ischemic optic neuropathy could not be established.

Health systems must prepare for the growing impact of cell and gene therapies by addressing their high costs, complex care pathways, and payer collaboration needs to ensure timely and sustainable ...